Hyman Charles D Medtronic PLC Transaction History

Hyman Charles D

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$76.72 - $87.58 $8,285 - $9,458	-108 Reduced 3.6%	2,888 $232,000
Q2 2022 Aug 02, 2022	BUY	$87.4 - $113.09 $87,400 - $113,090	1,000 Added 50.1%	2,996 $269,000
Q4 2021 Feb 08, 2022	BUY	$99.53 - $127.75 $2,786 - $3,577	28 Added 1.42%	1,996 $206,000
Q2 2021 Aug 05, 2021	SELL	$118.19 - $131.5 $2,600 - $2,893	-22 Reduced 1.11%	1,968 $244,000
Q1 2021 Apr 28, 2021	SELL	$111.18 - $119.74 $6,003 - $6,465	-54 Reduced 2.64%	1,990 $235,000
Q4 2020 Feb 08, 2021	SELL	$100.57 - $117.14 $141,904 - $165,284	-1,411 Reduced 40.84%	2,044 $239,000
Q3 2020 Oct 26, 2020	BUY	$90.13 - $108.78 $9,013 - $10,878	100 Added 2.98%	3,455 $359,000
Q2 2020 Aug 06, 2020	BUY	$84.11 - $103.33 $5,383 - $6,613	64 Added 1.94%	3,355 $308,000
Q4 2019 Feb 03, 2020	BUY	$104.49 - $114.54 $86,308 - $94,610	826 Added 33.51%	3,291 $373,000
Q2 2019 Jul 24, 2019	BUY	$84.15 - $99.38 $207,429 - $244,971	2,465 New	2,465 $240,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

Stay updated on Hyman Charles D with notifications on news.